Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication
- PMID: 33993458
- DOI: 10.1007/s12033-021-00334-7
Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication
Abstract
Topoisomerase II beta (Topo IIβ) is one of the two isoforms of type II topoisomerases present in higher eukaryotes. This 180 kDa nuclear protein involves in different cellular processes like transcription, recombination, etc., apart from its normal topological functions. Previously, we have reported the association of this isoform along with the other isoform topoisomerase II alpha (Topo IIα) with HIV-1 reverse transcription complex and the downregulation of Topo IIβ expression resulted in incomplete reverse transcription. In this study, we have tested the Topo IIβ specific siRNA delivery using protein nanoparticles prepared with c-terminal domine of transferrin (c-ter) for the first time. Results show that, c-ter nanoparticles resemble apotransferrin nanoparticles in drug holding capability and drug delivery but with small in size. Topo IIβ specific siRNA delivered in the form of c-ter nanoformulation resulted in knockdown of Topo IIβ expression for the prolonged periods and which intern resulted in decreased viral replication of HIV-1.
Keywords: Apotransferrin; Gene silencing; HIV-1; Nanoparticles; Topoisomerase IIβ; siRNA.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Curcumin-loaded apotransferrin nanoparticles provide efficient cellular uptake and effectively inhibit HIV-1 replication in vitro.PLoS One. 2011;6(8):e23388. doi: 10.1371/journal.pone.0023388. Epub 2011 Aug 22. PLoS One. 2011. PMID: 21887247 Free PMC article.
-
Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription.Arch Biochem Biophys. 2013 Apr 15;532(2):91-102. doi: 10.1016/j.abb.2013.01.010. Epub 2013 Feb 9. Arch Biochem Biophys. 2013. PMID: 23399433
-
Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.Nucleic Acids Res. 2017 Jun 2;45(10):5995-6010. doi: 10.1093/nar/gkx325. Nucleic Acids Res. 2017. PMID: 28472494 Free PMC article.
-
The Roles of DNA Topoisomerase IIβ in Transcription.Int J Mol Sci. 2018 Jun 29;19(7):1917. doi: 10.3390/ijms19071917. Int J Mol Sci. 2018. PMID: 29966298 Free PMC article. Review.
-
HIV-1 associated Topoisomerase IIβ kinase: a potential pharmacological target for viral replication.Curr Pharm Des. 2013;19(26):4776-86. doi: 10.2174/1381612811319260008. Curr Pharm Des. 2013. PMID: 23260019 Review.
Cited by
-
Navigating Latency-Inducing Viral Infections: Therapeutic Targeting and Nanoparticle Utilization.Biomater Res. 2024 Oct 16;28:0078. doi: 10.34133/bmr.0078. eCollection 2024. Biomater Res. 2024. PMID: 39416703 Free PMC article. Review.
References
-
- Osheroff, N. (1989). Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacology & Therapeutics, 41(1–2), 223–241 - DOI
-
- Zini, N., Martelli, A. M., Sabatelli, P., Santi, S., Negri, C., Astaldi Ricotti, G. C., & Maraldi, N. M. (1992). The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Experimental Cell Research, 200(2), 460–466 - DOI
-
- Capranico, G., Tinelli, S., Austin, C. A., Fisher, M. L., & Zunino, F. (1992). Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochimica et Biophysica Acta, 1132(1), 43–48 - DOI
-
- Yang, X., Li, W., Prescott, E. D., Burden, S. J., & Wang, J. C. (2000). DNA topoisomerase IIbeta and neural development. Science, 287(5450), 131–134 - DOI
-
- Tsutsui, K., Tsutsui, K., Sano, K., Kikuchi, A., & Tokunaga, A. (2001). Involvement of DNA topoisomerase IIbeta in neuronal differentiation. The Journal of Biological Chemistry, 276(8), 5769–5778. https://doi.org/10.1074/jbc.M008517200 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources